These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35058123)
21. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia. Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990 [TBL] [Abstract][Full Text] [Related]
22. [Parkinson's disease associated to mutation of the LRRK2 gene, mimicking multisystemic atrophy due to the combination of parkinsonism, early-onset dysautonomia and normal cardiac scintigraphy]. Vilas D; Muxi A; Tolosa E; Compta Y Rev Neurol; 2016 Jul; 63(2):95-6. PubMed ID: 27377986 [No Abstract] [Full Text] [Related]
24. Leucine-Rich Repeat Kinase (LRRK2) Genetics and Parkinson's Disease. Monfrini E; Di Fonzo A Adv Neurobiol; 2017; 14():3-30. PubMed ID: 28353276 [TBL] [Abstract][Full Text] [Related]
25. Association of Dual LRRK2 G2019S and GBA Variations With Parkinson Disease Progression. Ortega RA; Wang C; Raymond D; Bryant N; Scherzer CR; Thaler A; Alcalay RN; West AB; Mirelman A; Kuras Y; Marder KS; Giladi N; Ozelius LJ; Bressman SB; Saunders-Pullman R JAMA Netw Open; 2021 Apr; 4(4):e215845. PubMed ID: 33881531 [TBL] [Abstract][Full Text] [Related]
26. LRRK2 G2019S Mutation Inhibits Degradation of α-Synuclein in an In Vitro Model of Parkinson's Disease. Hu D; Niu JY; Xiong J; Nie SK; Zeng F; Zhang ZH Curr Med Sci; 2018 Dec; 38(6):1012-1017. PubMed ID: 30536063 [TBL] [Abstract][Full Text] [Related]
27. Nonmotor symptoms in LRRK2 G2019S associated Parkinson's disease. Gaig C; Vilas D; Infante J; Sierra M; García-Gorostiaga I; Buongiorno M; Ezquerra M; Martí MJ; Valldeoriola F; Aguilar M; Calopa M; Hernandez-Vara J; Tolosa E PLoS One; 2014; 9(10):e108982. PubMed ID: 25330404 [TBL] [Abstract][Full Text] [Related]
28. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease. Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749 [TBL] [Abstract][Full Text] [Related]
29. Sex effects on clinical features in LRRK2 G2385R carriers and non-carriers in Parkinson's disease. Cui SS; Fu R; Du JJ; Lin YQ; Huang P; Gao C; Zhou HY; Chen SD BMC Neurosci; 2021 Mar; 22(1):22. PubMed ID: 33771108 [TBL] [Abstract][Full Text] [Related]
30. Comparative study of Parkinson's disease and leucine-rich repeat kinase 2 p.G2019S parkinsonism. Trinh J; Amouri R; Duda JE; Morley JF; Read M; Donald A; Vilariño-Güell C; Thompson C; Szu Tu C; Gustavsson EK; Ben Sassi S; Hentati E; Zouari M; Farhat E; Nabli F; Hentati F; Farrer MJ Neurobiol Aging; 2014 May; 35(5):1125-31. PubMed ID: 24355527 [TBL] [Abstract][Full Text] [Related]
31. Parkinson disease phenotype in Ashkenazi Jews with and without LRRK2 G2019S mutations. Alcalay RN; Mirelman A; Saunders-Pullman R; Tang MX; Mejia Santana H; Raymond D; Roos E; Orbe-Reilly M; Gurevich T; Bar Shira A; Gana Weisz M; Yasinovsky K; Zalis M; Thaler A; Deik A; Barrett MJ; Cabassa J; Groves M; Hunt AL; Lubarr N; San Luciano M; Miravite J; Palmese C; Sachdev R; Sarva H; Severt L; Shanker V; Swan MC; Soto-Valencia J; Johannes B; Ortega R; Fahn S; Cote L; Waters C; Mazzoni P; Ford B; Louis E; Levy O; Rosado L; Ruiz D; Dorovski T; Pauciulo M; Nichols W; Orr-Urtreger A; Ozelius L; Clark L; Giladi N; Bressman S; Marder KS Mov Disord; 2013 Dec; 28(14):1966-71. PubMed ID: 24243757 [TBL] [Abstract][Full Text] [Related]